Value creation Model

Shionogi’s Company Policy is to strive “constantly to supply the best possible medicine to protect the health and wellbeing of the patients we serve.” Based on this, we are working on material issues (materiality) so that we will provide new value to customers and society through our business activities and thus attain growth and a sustainable society. Shionogi’s value creation process consists of creating innovative products and services as a drug discovery-based pharmaceutical company while resolving social issues and responding to healthcare needs so that we can grow as a company that society needs, and sharing the fruits of these efforts with all our stakeholders. We are going to transform ourselves into a HaaS company that continues developing its strengths cultivated as a drug discovery-based pharmaceutical company that works with diverse partners who possess different strengths to supply healthcare solutions.